Serologic Assays for the Diagnosis of Herpes Simplex Virus Type 2

Completed

Conditions studied: Genital Herpes

In brief

The purposes of this study are: * To determine the accuracy of commercially available serologic assays in diagnosing patients with herpes simplex virus type 2 (HSV-2); * To assess the sensitivity and specificity of the commerical assays using HSV-2 western blot as the "gold standard" in a diverse patient population; * To develop testing strategies and recommendations for screening asymptomatic populations for HSV-2.

Key facts

Study ID

NCT01112956

Run by

Centers for Disease Control and Prevention

People needed

2500

Starts

2009-07-01

Expected to finish

2011-02-01

Last updated by the study team

2011-03-23

Who can join

Age: 16 and older, up to 55. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Men and women 16-55 years of age

You may not qualify if…

• Those who refuse to get tested for HIV

Where it is running

• John Hopkins University — Baltimore, Maryland, United States
• Massachusetts General Hospital — Boston, Massachusetts, United States
• New York University School of Medicine — New York, New York, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.